Binding term sheet grants Modulant Biosciences exclusive global rights to develop and commercialize EL-22 for animal health, enabling a first-of-its-kind…
Several Key Clinical Readouts in Addition to New Study Initiations Expected in 2025SOLANA BEACH, Caif., May 13, 2025 (GLOBE NEWSWIRE) --…
Topline pharmacodynamic biomarker, safety and tolerability results from a Phase 1 study of OV329 are on track to readout in…
The GBP/USD price analysis shows a surging pound. The UK claimant count increased by 5,200, well below forecasts of 22,300.…
Sheridan, Wyoming, May 13, 2025 (GLOBE NEWSWIRE) -- Brighter A.M.'s Morning Magic has exploded across social media after being dubbed…
JACKSONVILLE, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Landstar System, Inc. (NASDAQ: LSTR) (“Landstar” or the “Company”) today reported basic…
Raanana, Israel, May 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech…
HOUSTON, May 13, 2025 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), a leading space technology…
Progress continues in Phase 3 Orbit study of setrusumab in osteogenesis imperfecta (OI) Cash of $62.5 million as of March…
Updated data from ongoing Phase 1/1b trial in 1L R/M HNSCC to be presented at 2025 ASCO Annual Meeting Enrollment…
This website uses cookies.